Pilot Study for Zoledronic Acid to Prevent Bone Loss After Bariatric Surgery

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

January 1, 2020

Study Completion Date

January 1, 2020

Conditions

Bariatric Surgery Candidate

Interventions

DRUG

Zoledronic Acid

5mg zoledronic acid

DIETARY_SUPPLEMENT

Calcium citrate + vitamin D

Chewable 500mg calcium citrate with 500 International Units (IU) Vitamin D3

DIETARY_SUPPLEMENT

Vitamin D3

1000IU Vitamin D3 gummy

Trial Locations (1)

Massachusetts General Hospital, Boston

All Listed Sponsors

lead

Massachusetts General Hospital

OTHER

NCT03424239 - Pilot Study for Zoledronic Acid to Prevent Bone Loss After Bariatric Surgery | Biotech Hunter | Biotech Hunter